12-Week, Double-Blind, Placeob-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa

This study has been completed.
Sponsor:
Information provided by:
Kyowa Hakko Kirin Pharma, Inc.
ClinicalTrials.gov Identifier:
NCT00456794
First received: April 3, 2007
Last updated: June 22, 2010
Last verified: April 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2003
  Estimated Primary Completion Date: No date given
No publications provided by Kyowa Hakko Kirin Pharma, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):